{"input_url":"https://www.directorstalkinterviews.com/peptide-drug-development-expands-beyond-glp-1/4121263504","gnews_decode":"https://www.directorstalkinterviews.com/peptide-drug-development-expands-beyond-glp-1/4121263504","http_status":200,"final_url":"https://www.directorstalkinterviews.com/peptide-drug-development-expands-beyond-glp-1/4121263504","html_length":279769,"trafilatura_result":"ok","text_length":2372,"text_preview":"GLP-1 medicines have pushed peptide therapies into the mainstream. The next question is whether that success can extend into a broader generation of peptide drugs targeting more complex diseases. Research is already moving in that direction.\nDevelopers are exploring peptides that act on multiple rec","verdict":"OK"}